Immunotherapy in Small Cell Lung Cancer

SIMPLE SUMMARY: Small cell lung cancer (SCLC) accounts for about 15% of lung cancers and it has limited therapeutic options and poor prognosis. There has been no real progress for over 30 years in the treatment of this aggressive tumor type and platinum based chemotherapy represented the cornerstone...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Giovanna, Palumbo, Giuliano, Carillio, Guido, Manzo, Anna, Montanino, Agnese, Sforza, Vincenzo, Costanzo, Raffaele, Sandomenico, Claudia, La Manna, Carmine, Martucci, Nicola, La Rocca, Antonello, De Luca, Giuseppe, Piccirillo, Maria Carmela, De Cecio, Rossella, Botti, Gerardo, Totaro, Giuseppe, Muto, Paolo, Picone, Carmine, Normanno, Nicola, Morabito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565004/
https://www.ncbi.nlm.nih.gov/pubmed/32899891
http://dx.doi.org/10.3390/cancers12092522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565004/
https://www.ncbi.nlm.nih.gov/pubmed/32899891
http://dx.doi.org/10.3390/cancers12092522

Ejemplares similares